Trial intelligence / Profile preview

Sensitivity and Specificity of Aridol Challenge in Suspected Asthma

NCT00252291Phase 3Completed

Sponsor
Syntara Limited
Start
Nov 2005
Modality
Inhalation Devices, Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Bronchitol in asthma, sponsored by Syntara Limited. Started Nov 2005; status: completed.

02

Drugs

Bronchitol
03

Conditions

asthma

Beyond the preview

Go deeper on NCT00252291.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00252291.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call